Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib
Hairy cell leukemia (HCL) and HCL-like disorders such as hairy cell leukemia variant (HCL-V) and splenic diffuse red pulp lymphoma (SDRPL) are rare indolent B-cell malignancies. Purine analogs (PNAs), alone or in association with rituximab (R), are the standard of care for HCL in the first-line sett...
Main Authors: | Jérôme Paillassa, Firas Safa, Xavier Troussard |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-04-01
|
Series: | Therapeutic Advances in Hematology |
Online Access: | https://doi.org/10.1177/20406207221090886 |
Similar Items
-
Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders
by: Elsa Maitre, et al.
Published: (2022-02-01) -
Protein profiling by reverse phase protein array (RPPA) in classical hairy cell leukemia (HCL) and HCL‐variant
by: Fieke W. Hoff, et al.
Published: (2022-11-01) -
Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders
by: Elsa Maitre, et al.
Published: (2022-12-01) -
Chromatographic methods for the simultaneous determination of binary mixture of Saxagliptin HCl and Metformin HCl
by: Hanan A. Merey, et al.
Published: (2017-12-01) -
Anti-malarial activity of HCl salt of SKM13 (SKM13-2HCl)
by: Thuy-Tien Thi Trinh, et al.
Published: (2022-12-01)